Walgreens Boots Alliance "has been able to make up for its weak stock market performance by offering one of the juiciest dividends on the market," but its payout will be harder to justify going forward with debt levels rising and earnings "erratic," according to a report published by Activist Insight. The activist-focused publication speculates that an "activist could take advantage of the depressed valuation to take a significant stake and demand operational improvements and balance sheet management to make sure that doesn’t happen," contacts tell The Fly.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on WBA:
- Walgreens and Prothena team to increase enrollment in Alzheimer’s trial
- Walgreens Boots Alliance price target lowered to $46 from $47 at Deutsche Bank
- Walgreens Boots Alliance price target lowered to $37 from $39 at UBS
- Walgreens Boots Alliance price target lowered to $40 from $42 at Truist
- Walgreens Boots Alliance Inc. Earnings Update: Did it Beat Estimate Forecasts?
